The business model of Encision Inc is focused on the development, manufacturing, and marketing of surgical devices. Specializing in medical technology, Encision Inc aims to enhance patient safety and surgical outcomes by providing innovative instruments for minimally invasive procedures. The company offers a range of advanced energy surgical devices, including the AEM® technology platform, which allows surgeons to precisely deliver energy to target tissue while minimizing thermal injury. Encision Inc strives to continuously improve surgical techniques and patient care through its cutting-edge products.

Encision Inc is primarily active in the medical technology industry.

The main competitors of Encision Inc in the market include companies such as Medtronic, Aesculap, Olympus Corporation, and CONMED Corporation.

Encision Inc is a renowned medical device company established in 1991. With its headquarters in Boulder, Colorado, Encision specializes in designing, manufacturing, and marketing innovative surgical instruments. The company is dedicated to advancing patient safety and surgical outcomes by providing surgeons with cutting-edge technology. Encision Inc offers a range of products, including electrosurgical instruments, laparoscopic instrumentation, and related accessories. With a focus on delivering superior quality and performance, Encision Inc has built a solid reputation in the healthcare industry. Its commitment to innovation and patient care positions Encision as a trusted leader in the market.

Encision Inc has achieved several significant milestones. The company successfully developed and launched a line of innovative medical devices and surgical instruments aimed at enhancing patient safety and improving surgical outcomes. Encision Inc also received FDA clearance for its flagship product, the Active Electrode Monitoring (AEM) technology, which provides real-time monitoring of tissue health during surgery. Additionally, the company secured multiple patents for its unique technologies and garnered recognition for its commitment to quality and safety in the healthcare industry. Encision Inc continues to advance its product portfolio and expand its presence in the market, reinforcing its position as a leader in the medical device industry.

Encision Inc is primarily present in the United States.

Encision Inc represents a strong commitment to patient safety and quality in healthcare. The company's corporate philosophy is centered around providing innovative surgical technology that enhances patient outcomes. Encision Inc values integrity, collaboration, and continuous improvement in order to deliver cutting-edge solutions to the medical industry. By combining advanced technology and a dedication to patient well-being, Encision Inc aims to revolutionize surgical procedures and ensure the highest standards of care. With a relentless focus on improving patient safety, Encision Inc strives to be a trusted partner for healthcare professionals worldwide.

Converted at the current exchange rate, the Encision share trades at 0.00 EUR (0.00 USD).

Encision Inc. is a leading manufacturer of medical devices and develops and distributes innovative products that contribute to making surgical procedures safer, faster, and more effective. Encision's business model is based on two main divisions: the sale of medical devices and services related to training and support. The company specializes in the development of high-frequency generators used during surgery to control bleeding and cut tissue. Encision's devices regulate the flow of electricity in a way that significantly reduces the risk of burns during surgery. Additionally, Encision offers training courses, workshops, technical support, and maintenance services for healthcare professionals. The company's range of medical devices includes high-frequency generators, laparoscopic instruments, surgical forceps, trocars, and consumables such as electrodes and loops. Encision's products are designed to meet the specific needs of minimally invasive procedures and provide excellent precision and control. In summary, Encision focuses on the development, sale, and support of medical devices, with a specialization in high-frequency generators. The company aims to reduce the risk of burns during surgery while enabling higher precision. Encision also offers training and support services to ensure that users can fully utilize the potential of their devices.

The revenue cannot currently be calculated for Encision.

The profit cannot currently be calculated for Encision.

The P/E ratio cannot be calculated for Encision at the moment.

The P/S cannot be calculated for Encision currently.

The Eulerpool Quality Score for Encision is 1/10.

The ISIN of Encision is US29254Q1040. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Encision is 813209. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Encision is ECIA. The ticker symbol is used to trade Encision shares on the stock exchange.

Encision paid dividends every year for the past 0 years.

Encision is assigned to the 'Health' sector.

The dividends of Encision are distributed in USD.